RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. ARCH Venture Partners
A

ARCH Venture Partners portfolio

ARCH Venture Partners has 29 portfolio companies on record at Recent Funding, with 5 investments in the last 12 months.

Website: archventure.com.
Type: Venture capital.
Portfolio on Recent Funding: 29.
Deals, last 12 months: 5.
Rounds led: 11 of 31.
Capital in their rounds: $3.97B.
Latest deal: Oratomic · Oct 8, 2026.
About this page

It is a venture capital firm based in Chicago, US, founded in 1989. It led 11 of the 31 rounds it joined. Its most recent investment on record is Oratomic's $475M Series B+ round in October 2026, which it led, alongside Khosla Ventures, General Catalyst, Bezos Expeditions and 2 others. By category, its portfolio leans toward Health and bio (26) and Robotics and hardware (4). It has co-invested with GV, Invus and OrbiMed, most often GV (8 rounds).

About ARCH Venture Partners

Firm type: Venture capital.
Headquarters: Chicago, US.
Founded: 1989.
Stages: Seed, Series A, Series B, Series C.
Sectors: AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices, Quantum Computing.
Check size: $50K to $250M.
Leads rounds: No.
Portfolio companies: 141.
Exits: 54.
Rounds led: 88.

Fund returns

FundVintageSizeNet IRRTVPIDPIAs of
ARCH VENTURE FUND XIII LP2023—39.8%1.25x0.00xDec 31, 2025
Arch IX Overage2016—26.0%2.85x1.89xJun 30, 2024
ARCH VENTURE FUND VI LP2003—2.4%1.24x1.24xJun 30, 2025
ARCH VENTURE FUND IX LP——24.2%2.58x1.53xJun 30, 2024
ARCH VENTURE FUND VIII LP——21.6%3.19x2.44xJun 30, 2024

What ARCH Venture Partners invests in

ARCH Venture Partners recent investments

How ARCH Venture Partners invests

StageDealsCapital in rounds
Series B+ 16 52%$1.88B
Series A 14 45%$2.08B
Seed 1 3%$6.5M
YearDealsCapital in rounds
2017 1 3%$55M
2018 1 3%$28.5M
2019 1 3%$6.5M
2020 1 3%$70M
2021 3 10%$175M
2022 6 19%$756M
2023 3 10%$420M
2024 6 19%$816M
2025 4 13%$526M
2026 5 16%$1.11B

ARCH Venture Partners portfolio companies

CompanyRound with ARCH Venture PartnersTotal raisedLatest raise
OOratomic
Robotics and hardware
Series B+ · $475M · lead$775MOct 8, 2026
Series B+
LLifeMine Therapeutics
Health and bio
Series B+ · $188M$543MAug 6, 2026
Series B+
SSynchron
Health and bio
Series B+ · $275M$600MJun 29, 2026
Series B+
CCity Therapeutics
Health and bio
Series B+ · $99.5M$234.5MAug 8, 2026
Series B+
EElephas Biosciences
Health and bio
Series B+ · $40M · lead$95MNov 6, 2025
Series B+
SSoufflé Therapeutics
Health and bio
Series A · $200M$335MOct 13, 2026
Series B+
TTreeline Biosciences
Health and bio
Series A · $200M$461MSep 3, 2025
Series A
RRhyGaze
Health and bio
Series A · $86M$97MJan 10, 2025
Series A
MMirador Therapeutics
Health and bio
Series A · $400M · lead$650MJan 13, 2026
Series B+
AAreteia Therapeutics
Health and bio
Series A · $75M$75MFeb 13, 2024
Series A
AAccompany Health
Health and bio
Series A · $56M$56MJan 30, 2024
Series A
HHI-Bio
Health and bio
Series B+ · $95M$215MJan 4, 2024
Series B+
MMagnet Biomedicine
Health and bio
Series A · $50M · lead$50MJul 13, 2026
Series A
OOrbital Therapeutics
Health and bio
Series A · $270M · lead$270MAug 3, 2025
Series A
PParatus Sciences
Health and bio
Series A · $100M · lead$100MMar 8, 2023
Series A
HHomeward Health
Health and bio
Series B+ · $50M · lead$50MAug 3, 2022
Series B+
OONI
Health and bio
Series B+ · $75M · lead$75MJan 29, 2022
Series B+
CCytrellis Biosystems
Health and bio
Series B+ · $50M$78.5MSep 21, 2021
Series B+
EEncodia
Health and bio
Series B+ · $75M$75MJun 26, 2024
Series A
AAspen Neuroscience
Health and bio
Series A · $70M$339MNov 20, 2025
Series B+
AAtlas Data Storage
AI infrastructure and compute
backer$161MMar 5, 2026
Seed
AArbor Biotechnologies
Health and bio
backer$289MMar 18, 2025
Series B+
TTenvie
Health and bio
backerundisclosedJan 8, 2025
round
LLightcast
Health and bio
backer$27MApr 14, 2026
round
AAkamis Bio
Health and bio
backer$60MDec 17, 2024
Series A
LLifordi Immunotherapeutics
Health and bio
backerundisclosedNov 18, 2025
Series A
QQuantum Circuits
Robotics and hardware
backer$78MAug 16, 2024
Series B+
Bbit.bio
Health and bio
backer$75MNov 4, 2026
Series B+
XXaira Therapeutics
Health and bio
backer$1BMar 23, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 31 rounds on Recent Funding that name ARCH Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists ARCH Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/arch-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy